Equities

Star Combo Pharma Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
S66:ASX

Star Combo Pharma Ltd

Actions
Consumer Staples Food Producers
  • Price (AUD)0.195
  • Today's Change0.00 / 0.00%
  • Shares traded13.50k
  • 1 Year change+50.00%
  • Beta0.9391
Data delayed at least 20 minutes, as of Feb 13 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Star Combo Pharma Limited is an Australia-based manufacturer and distributor of premium health and natural beauty products. The Company operates through two segments: the Star Combo business and the Austoyou retail business. The Star Combo business segment is engaged in the business of development, manufacturing, marketing and sales of natural health supplements and skin care products. The Austoyou retail business is made up of the Australia-China e-commerce platform that offers over 5,000 high-demand product lines directly to Chinese health product consumers. The Company’s product categories include Costar, Living Healthy, Amax, and J&K. The Company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance. The Company’s wholly owned subsidiaries include CoStar Pharma Laboratory Pty Ltd, Star Combo Australia Pty Ltd, Austoyou Group Pty Ltd, and Koala Mall Pty Ltd.

  • Revenue in AUD (TTM)28.24m
  • Net income in AUD5.25m
  • Incorporated2016
  • Employees--
  • Location
    Star Combo Pharma Ltd171 - 177 Woodpark Rd,, Smithfield 2164AustraliaAUS
  • Phone+61 (29) 756-6555
  • Fax+61 (28) 798-3088
  • Websitehttps://www.starcombo.com.au/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Eve Health Group Ltd1.73m-1.45m5.70m----1.39--3.28-0.0106-0.01150.01260.01440.52195.6028.68---43.71-39.42-60.84-45.2047.5041.65-83.76-128.081.65-1,136.020.025---18.70-5.586.18------
Wellnex Life Ltd23.63m-15.60m8.39m----0.723--0.3553-0.5486-0.54860.80740.1660.80027.866.83---52.85-70.99-178.26-207.62-27.7114.56-66.05-80.460.2593-3.470.3366--41.9588.49-13.57------
Star Combo Pharma Ltd28.24m5.25m26.34m--4.920.69183.680.93280.03970.03970.20910.28190.61893.818.23--11.50-2.9513.09-3.2723.7320.4518.59-5.043.5546.640.0932--7.46-6.29602.32---32.37--
Maggie Beer Holdings Ltd76.32m-14.21m34.50m76.00--0.8139--0.452-0.0402-0.06810.21060.09461.253.5512.73---23.20-5.88-28.98-6.7247.1949.58-18.62-7.980.6761-15.610.0956--3.7511.1229.96---6.64--
Data as of Feb 13 2026. Currency figures normalised to Star Combo Pharma Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.